The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Cardiovascular Function and Treatment in β-Thalassemia Major: A Consensus Statement From the American Heart Association
Open accessAbstract
This aim of this statement is to report an expert consensus on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover other hemoglobinopathies, including thalassemia intermedia and sickle cell anemia, in which a different spectrum of cardiovascular complications is typical. There are considerable uncertainties in this field, with a few randomized controlled trials relating to treatment of chronic myocardial siderosis but none relating to treatment of acute heart failure. The principles of diagnosis and treatment of cardiac iron loading in TM are directly relevant to other iron-overload conditions, including in particular Diamond-Blackfan anemia, sideroblastic anemia, and hereditary hemochromatosis. Heart failure is the most common cause of death in TM and primarily results from cardiac iron accumulation. The diagnosis of ventricular dysfunction in TM patients differs from that in nonanemic patients because of the cardiovascular adaptation to chronic anemia in non–cardiac-loaded TM patients, which includes resting tachycardia, low blood pressure, enlarged end-diastolic volume, high ejection fraction, and high cardiac output. Chronic anemia also leads to background symptomatology such as dyspnea, which can mask the clinical diagnosis of cardiac dysfunction. Central to early identification of cardiac iron overload in TM is the estimation of cardiac iron by cardiac T2* magnetic resonance. Cardiac T2* <10 ms is the most important predictor of development of heart failure. Serum ferritin and liver iron concentration are not adequate surrogates for cardiac iron measurement. Assessment of cardiac function by noninvasive techniques can also be valuable clinically, but serial measurements to establish trends are usually required because interpretation of single absolute values is complicated by the abnormal cardiovascular hemodynamics in TM and measurement imprecision. Acute decompensated heart failure is a medical emergency and requires urgent consultation with a center with expertise in its management. The first principle of management of acute heart failure is control of cardiac toxicity related to free iron by urgent commencement of a continuous, uninterrupted infusion of high-dose intravenous deferoxamine, augmented by oral deferiprone. Considerable care is required to not exacerbate cardiovascular problems from overuse of diuretics or inotropes because of the unusual loading conditions in TM. The current knowledge on the efficacy of removal of cardiac iron by the 3 commercially available iron chelators is summarized for cardiac iron overload without overt cardiac dysfunction. Evidence from well-conducted randomized controlled trials shows superior efficacy of deferiprone versus deferoxamine, the superiority of combined deferiprone with deferoxamine versus deferoxamine alone, and the equivalence of deferasirox versus deferoxamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationRecommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel-Aty, H., Gutberlet, M., Prasad, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,509
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDATE THE 2005 GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING COMMITTEE, Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192064 · Cited by 1,419
HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.004 · Cited by 1,290
Grothues, F., Smith, G. C., Moon, J. C. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02381-0 · Cited by 1,267
Self-citationBorgna‐Pignatti, C., Rugolotto, S., Stefano, P. D., Zhao, H., Cappellini, M. D., Vecchio, G. C. D., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., et al. (2004) · PubMed · Cited by 1,119
Self-citationCostanzo, M. R., Guglin, M. E., Saltzberg, M. T., Jessup, M. L., Bart, B. A., Teerlink, J. R., Jaski, B. E., Fang, J. C., Feller, E. D., Haas, G. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.073 · Cited by 1,117
Bellenger, N. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2011 · Cited by 1,040
Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome
Bart, B. A., Goldsmith, S. R., Lee, K. L., Givertz, M. M., O'Connor, C. M., Bull, D. A., Redfield, M. M., Deswal, A., Rouleau, J. L., LeWinter, M. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210357 · Cited by 999
Survival in Medically Treated Patients with Homozygous β-Thalassemia
Olivieri, N. F., Nathan, D. G., MacMillan, J. H., Wayne, A. S., Liu, P. P., McGee, A., Martin, M., Koren, G., & Cohen, A. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310903 · Cited by 852
Self-citationMaceira, A., Prasad, S., Khan, M., & Pennell, D. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600572889 · Cited by 847
Self-citationBrittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310902 · Cited by 829
Grothues, F., Moon, J. C., Bellenger, N. G., Smith, G. S., Klein, H. U., & Pennell, D. J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.005 · Cited by 776
Self-citationCappellini, M. D. (2006) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 717
Kramer, C. M., Barkhausen, J., Flamm, S. D., Kim, R. J., & Nagel, E. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-35 · Cited by 688
SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
Zurlo, M., De Stefano, P., Borgna-Pignatti, C., Di Palma, A., Melevendi, C., Piga, A., Di Gregorio, F., Burattini, M., & Terzoli, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90264-x · Cited by 611
Self-citationHepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
Angelucci, E., Brittenham, G. M., McLaren, C. E., Ripalti, M., Baronciani, D., Giardini, C., Galimberti, M., Polchi, P., & Lucarelli, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430503 · Cited by 607
Modell, B., Khan, M., Darlison, M., Westwood, M. A., Ingram, D., & Pennell, D. J. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-42 · Cited by 600
Self-citationCardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
Kirk, P., Roughton, M., Porter, J. B., Walker, J. M., Tanner, M. A., Patel, J., Wu, D., Taylor, J., Westwood, M. A., Anderson, L. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.874487 · Cited by 597
Self-citationSurvival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register
Modell, B., Khan, M., & Darlison, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02357-6 · Cited by 583
Maceira, A. M., Prasad, S. K., Khan, M., & Pennell, D. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl336 · Cited by 561
Self-citationPennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
Self-citationOn T2* Magnetic Resonance and Cardiac Iron
Carpenter, J.-P., He, T., Kirk, P., Roughton, M., Anderson, L. J., de Noronha, S. V., Sheppard, M. N., Porter, J. B., Walker, J. M., Wood, J. C., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.007641 · Cited by 485
Self-citationTanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Roughton, M., Assomull, R., Nair, S. V., Walker, J. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.648790 · Cited by 482
Self-citationOudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., Yazdanpanah, M., Wilson, G. J., Schwartz, A., Liu, P. P., et al. (2003) · Nature Medicine · doi:10.1038/nm920 · Cited by 480
Buja, L. M., & Roberts, W. C. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90240-3 · Cited by 472
Complications of β-thalassemia major in North America
Cunningham, M. J., Macklin, E. A., Neufeld, E. J., Cohen, A. R., & the Thalassemia Clinical Research Network (2004) · Blood · doi:10.1182/blood-2003-09-3167 · Cited by 454
Self-citationCaminiti, G., Volterrani, M., Iellamo, F., Marazzi, G., Massaro, R., Miceli, M., Mammi, C., Piepoli, M., Fini, M., & Rosano, G. M. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.078 · Cited by 444
Anderson, L. J., Wonke, B., Prescott, E., Holden, S., Malcolm Walker, J., & Pennell, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09740-4 · Cited by 430
Self-citationVisual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
Olivieri, N. F., Buncic, J. R., Chew, E., Gallant, T., Harrison, R. V., Keenan, N., Logan, W., Mitchell, D., Ricci, G., Skarf, B., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604033141402 · Cited by 429
OXIDANT MECHANISMS IN TOXIC ACUTE RENAL FAILURE*
BALIGA, R., UEDA, N., WALKER, P. D., & SHAH, S. V. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101947 · Cited by 426
Anderson, L. J., Westwood, M. A., Holden, S., Davis, B., Prescott, E., Wonke, B., Porter, J. B., Malcolm Walker, J., & Pennell, D. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05202.x · Cited by 414
Self-citationEaton, J. W., & Qian, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00772-4 · Cited by 389 · cited 1×
“In the heart, increased levels of intracellular free iron are toxic through a number of mechanisms,(66,67) including (1) damage to membranes by lipid peroxidation; (2) damage to mitochondria and the respiratory enzyme chain(68,69); (3) interference with electrical function, including ryanodine release channel interfer…”
Westwood, M., Anderson, L. J., Firmin, D. N., Gatehouse, P. D., Charrier, C. C., Wonke, B., & Pennell, D. J. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10332 · Cited by 379
Self-citationResults of Long-Term Iron-Chelating Therapy
Gabutti, V., & Piga, A. (2009) · Acta Haematologica · doi:10.1159/000203853 · Cited by 378
Self-citationBorgna-Pignatti, C. (2006) · Blood · doi:10.1182/blood-2005-07-2933 · Cited by 376
Iron-Chelating Therapy for Transfusional Iron Overload
Brittenham, G. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1004810 · Cited by 366
Liver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365
Self-citationIron Overload Cardiomyopathy in Clinical Practice
Kremastinos, D. T., & Farmakis, D. (2011) · Circulation · doi:10.1161/circulationaha.111.050773 · Cited by 355
Survival and Disease Complications in Thalassemia Major
BORGNA‐PIGNATTI, C., RUGOLOTTO, S., DE STEFANO, P., PIGA, A., DI GREGORIO, F., GAMBERINI, M. R., SABATO, V., MELEVENDI, C., CAPPELLINI, M. D., & VERLATO, G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10479.x · Cited by 343
Self-citationMyocardial iron loading in transfusion-dependent thalassemia and sickle cell disease
Wood, J. C., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2004) · Blood · doi:10.1182/blood-2003-06-1919 · Cited by 341
Self-citationAngelucci, E., Muretto, P., Nicolucci, A., Baronciani, D., Erer, B., Gaziev, J., Ripalti, M., Sodani, P., Tomassoni, S., Visani, G., et al. (2002) · Blood · doi:10.1182/blood.v100.1.17 · Cited by 311
Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment
Murphy, C. J., & Oudit, G. Y. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.009 · Cited by 308
Cardiac involvement in thalassemia intermedia: a multicenter study
Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J., & Loukopoulos, D. (2001) · Blood · doi:10.1182/blood.v97.11.3411 · Cited by 298
Cappellini, M. D., Porter, J., El-Beshlawy, A., Li, C. K., Seymour, J. F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J. W., Chan, L. L., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.014696 · Cited by 288
Self-citationDavis, B. A., & Porter, J. B. (2000) · Blood · doi:10.1182/blood.v95.4.1229.004k32_1229_1236 · Cited by 279
Self-citationLivrea, M., Tesoriere, L., Pintaudi, A., Calabrese, A., Maggio, A., Freisleben, H., D'Arpa, D., D'Anna, R., & Bongiorno, A. (1996) · Blood · doi:10.1182/blood.v88.9.3608.bloodjournal8893608 · Cited by 274
Wilkoff, B. L., Bello, D., Taborsky, M., Vymazal, J., Kanal, E., Heuer, H., Hecking, K., Johnson, W. B., Young, W., Ramza, B., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2010.10.002 · Cited by 266
Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem
Vogiatzi, M. G., Macklin, E. A., Fung, E. B., Cheung, A. M., Vichinsky, E., Olivieri, N., Kirby, M., Kwiatkowski, J. L., Cunningham, M., Holm, I. A., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080505 · Cited by 252
Farmaki, K., Tzoumari, I., Pappa, C., Chouliaras, G., & Berdoukas, V. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07970.x · Cited by 252
Late Cardiac Complications of Chronic, Severe, Refractory Anemia with Hemochromatosis
ENGLE, M. A., ERLANDSON, M., & SMITH, C. H. (1964) · Circulation · doi:10.1161/01.cir.30.5.698 · Cited by 241
Telfer, P. T., Prestcott, E., Holden, S., Walker, M., Hoffbrand, A. V., & Wonke, B. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02298.x · Cited by 240
Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Pibiri, M., Nair, S. V., Walker, J. M., & Pennell, D. J. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-12 · Cited by 238
Self-citationCardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy
Wood, J. C., Otto-Duessel, M., Aguilar, M., Nick, H., Nelson, M. D., Coates, T. D., Pollack, H., & Moats, R. (2005) · Circulation · doi:10.1161/circulationaha.104.504415 · Cited by 236
Self-citationRosenthal, D., Chrisant, M. R. K., Edens, E., Mahony, L., Canter, C., Colan, S., Dubin, A., Lamour, J., Ross, R., Shaddy, R., et al. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.03.018 · Cited by 228
Piga, A. G., Gaglioti, C. M., Fogliacco, E., & Tricta, F. (2003) · PubMed · Cited by 222
Self-citationLongitudinal analysis of heart and liver iron in thalassemia major
Noetzli, L. J., Carson, S. M., Nord, A. S., Coates, T. D., & Wood, J. C. (2008) · Blood · doi:10.1182/blood-2008-04-148767 · Cited by 221
Self-citationCombined therapy with deferiprone and desferrioxamine
Wonke, Wright, & Hoffbrand (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01002.x · Cited by 218
Survival and desferrioxamine in thalassaemia major.
Modell, B., Letsky, E. A., Flynn, D. M., Peto, R., & Weatherall, D. J. (1982) · BMJ · doi:10.1136/bmj.284.6322.1081 · Cited by 206
Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia
Pennell, D. J., Porter, J. B., Cappellini, M. D., El-Beshlawy, A., Chan, L. L., Aydinok, Y., Elalfy, M. S., Sutcharitchan, P., Li, C.-K., Ibrahim, H., et al. (2010) · Blood · doi:10.1182/blood-2009-04-217455 · Cited by 195
Self-citationPepe, A., Positano, V., Santarelli, M. F., Sorrentino, F., Cracolici, E., De Marchi, D., Maggio, A., Midiri, M., Landini, L., & Lombardi, M. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20566 · Cited by 193
Telfer, P. T., Coen, P. G., Christou, S., Hadjigavriel, M., Kolnakou, A., Pangalou, E., Pavlides, N., Psiloines, M., Simamonian, K., Skordos, G., et al. (2006) · PubMed · Cited by 190
Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
Porter, Abeysinghe, R., Marshall, L., Hider, R., & Singh, S. (1996) · Blood · doi:10.1182/blood.v88.2.705.bloodjournal882705 · Cited by 187
β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability
Ataga, K. I., Cappellini, M. D., & Rachmilewitz, E. A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06740.x · Cited by 183
Davis, B. A., O'Sullivan, C., Jarritt, P. H., & Porter, J. B. (2004) · Blood · doi:10.1182/blood-2003-08-2841 · Cited by 180
Self-citationCardiac status in well‐treated patients with thalassemia major
Aessopos, A., Farmakis, D., Hatziliami, A., Fragodimitri, C., Karabatsos, F., Joussef, J., Mitilineou, E., Diamanti‐Kandaraki, E., Meletis, J., & Karagiorga, M. (2004) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00304.x · Cited by 179
Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR
Maffei, E., Messalli, G., Martini, C., Nieman, K., Catalano, O., Rossi, A., Seitun, S., Guaricci, A. I., Tedeschi, C., Mollet, N. R., et al. (2012) · European Radiology · doi:10.1007/s00330-011-2345-6 · Cited by 178
Pathogenesis and management of iron toxicity in thalassemia
Hershko, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05544.x · Cited by 176
Hepatocellular carcinoma in the thalassaemia syndromes
Borgna‐Pignatti, C., Vergine, G., Lombardo, T., Cappellini, M. D., Cianciulli, P., Maggio, A., Renda, D., Lai, M. E., Mandas, A., Forni, G., et al. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04732.x · Cited by 174
Self-citationJensen, P. D., Jensen, F. T., Christensen, T., Eiskjær, H., Baandrup, U., & Nielsen, J. L. (2003) · Blood · doi:10.1182/blood-2002-09-2754 · Cited by 174
Pancreatic iron loading predicts cardiac iron loading in thalassemia major
Noetzli, L. J., Papudesi, J., Coates, T. D., & Wood, J. C. (2009) · Blood · doi:10.1182/blood-2009-06-225615 · Cited by 170
Self-citationHepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century
Dwyre, D. M., Fernando, L. P., & Holland, P. V. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01426.x · Cited by 169
Westwood, M. A., Anderson, L. J., Firmin, D. N., Gatehouse, P. D., Lorenz, C. H., Wonke, B., & Pennell, D. J. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10396 · Cited by 166
Self-citationMyocardial Iron Loading in Patients with Thalassemia Major on Deferoxamine Chelation
Tanner, M., Galanello, R., Dessi, C., Westwood, M., Smith, G., Nair, S., Anderson, L., Walker, J., & Pennell, D. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600698155 · Cited by 166
Self-citationDiuretics and Ultrafiltration in Acute Decompensated Heart Failure
Felker, G. M., & Mentz, R. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.910 · Cited by 165
Rathi, V. K., Doyle, M., Yamrozik, J., Williams, R. B., Caruppannan, K., Truman, C., Vido, D., & Biederman, R. W. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-36 · Cited by 162
Diabetic cardiomyopathy—fact or fiction?
Maisch, B., Alter, P., & Pankuweit, S. (2011) · Herz · doi:10.1007/s00059-011-3429-4 · Cited by 161
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1
Ludwiczek, S., Theurl, I., Muckenthaler, M. U., Jakab, M., Mair, S. M., Theurl, M., Kiss, J., Paulmichl, M., Hentze, M. W., Ritter, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1542 · Cited by 160
Kirk, P., He, T., Anderson, L. J., Roughton, M., Tanner, M. A., Lam, W. W. M., Au, W. Y., Chu, W. C. W., Chan, G., Galanello, R., et al. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22245 · Cited by 159
Self-citationOxidant, antioxidant status and metabolic data in patients with beta-thalassemia
Kassab-Chekir, A., Laradi, S., Ferchichi, S., Khelil, A. H., Feki, M., Amri, F., Selmi, H., Béjaoui, M., & Miled, A. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.07.010 · Cited by 158
Arterial Stiffness and Endothelial Function in Patients With β-Thalassemia Major
Cheung, Y., Chan, G., & Ha, S. (2002) · Circulation · doi:10.1161/01.cir.0000037225.92759.a7 · Cited by 153
Pepe, A., Meloni, A., Capra, M., Cianciulli, P., Prossomariti, L., Malaventura, C., Putti, M. C., Lippi, A., Romeo, M. A., Bisconte, M. G., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.019042 · Cited by 149
High nontransferrin bound iron levels and heart disease in thalassemia major
Piga, A. G., Longo, F., Duca, L., Roggero, S., Vinciguerra, T., Calabrese, R., Hershko, C., & Cappellini, M. D. (2008) · American Journal of Hematology · doi:10.1002/ajh.21317 · Cited by 146
Self-citationThe effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
Wood, J. C., Kang, B. P. S., Thompson, A. A., Giardina, P. J., Harmatz, P., Glynos, T., Paley, C. S., & Coates, T. D. (2010) · Blood · doi:10.1182/blood-2009-11-250308 · Cited by 145
Self-citationPhysiology and Pathophysiology of Iron Cardiomyopathy in Thalassemia
Wood, J. C., Enriquez, C. M., Ghugre, N. R., Otto‐Duessel, M., Aguilar, M. I., Nelson, M. D., Moats, R. A., & Coates, T. D. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.047 · Cited by 145
Self-citationHeart cells in culture: a model of myocardial iron overload and chelation.
Link, G., Pinson, A., & Hershko, C. (1985) · PubMed · Cited by 141
Pennell, D. J., Porter, J. B., Cappellini, M. D., Chan, L. L., El-Beshlawy, A. M., Aydınok, Y., Ibrahim, H. M., Li, C. K., Viprakasit, V., Elalfy, M. S., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.049957 · Cited by 141
Self-citationMourad, F. H., Hoffbrand, A. V., Sheikh‐Taha, M., Koussa, S., Khoriaty, A. I., & Taher, A. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04240.x · Cited by 140
Tucci, A., Matta, G., Deplano, S., Gabbas, A., Depau, C., Derudas, D., Caocci, G., Agus, A., & Angelucci, E. (2008) · Haematologica · doi:10.3324/haematol.12759 · Cited by 140
Heart failure in beta thalassemia: a 5-year follow-up study
Kremastinos, D. T. H., Tsetsos, G. A., Tsiapras, D. P., Karavolias, G., Ladis, V., & KATTAMIS, C. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00879-8 · Cited by 135
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective
Musallam, K. M., Cappellini, M. D., Wood, J. C., & Taher, A. T. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70006-1 · Cited by 133
Self-citationSickle‐cell disease and the heart: review of the current literature
Voskaridou, E., Christoulas, D., & Terpos, E. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09143.x · Cited by 132
Pregnancy and -thalassemia: an Italian multicenter experience
Origa, R., Piga, A. G., Quarta, G., Forni, G. L., Longo, F., Melpignano, A., & Galanello, R. (2009) · Haematologica · doi:10.3324/haematol.2009.012393 · Cited by 131
Self-citationMyocarditis in β-Thalassemia Major
Kremastinos, D. T., Tiniakos, G., THEODORAKIS, G. N., Katritsis, D. G., & TOUTOUZAS, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.66 · Cited by 129
Eldor, A., Durst, R. Y., Hyam, E., Goldfarb, A. W., Gillis, S., Rachmilewitz, E. A., Abramov, A., Maclouf, J., Godefray, Y. C., de Raucourt, E., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01758.x · Cited by 128
Evaluation of the efficacy of oral deferiprone in β‐thalassemia major by multislice multiecho T2*
Pepe, A., Lombardi, M., Positano, V., Cracolici, E., Capra, M., Malizia, R., Prossomariti, L., Marchi, D. D., Midiri, M., & Maggio, A. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00587.x · Cited by 125
Leon, M. B., BORER, J. S., Bacharach, S. L., Green, M. V., Benz, E. J. J., Griffith, P. M., & Nienhuis, A. W. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911223012103 · Cited by 125
Westwood, M. A., Firmin, D. N., Gildo, M., Galanello, R., Gotsis, S. D., Karagiorga, M., Vasili, B., & Pennell, D. J. (2005) · International journal of cardiac imaging · doi:10.1007/s10554-005-0651-2 · Cited by 122
Self-citationCardiac Involvement in Cooley's Anemia
Engle, M. A. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb54070.x · Cited by 122
Nault, I., Miyazaki, S., Forclaz, A., Wright, M. J., Jadidi, A., Jaïs, P., Hocini, M., & Haïssaguerre, M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq079 · Cited by 122
Jensen, P. D. Ø., Jensen, F. T., Christensen, T., Nielsen, J. L., & Ellegaard, J. (2002) · Blood · doi:10.1182/blood-2002-06-1704 · Cited by 121
Lekawanvijit, S., & Chattipakorn, N. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70064-9 · Cited by 121
FITCHETT, D. H., COLTART, D. J., Littler, W. A., Leyland, M. J., Trueman, T., Gozzard, D., & Peters, T. J. (1980) · Cardiovascular Research · doi:10.1093/cvr/14.12.719 · Cited by 119
Arnold, J. M. O., Howlett, J. G., Ducharme, A., Ezekowitz, J. A., Gardner, M. J., Giannetti, N., Haddad, H. A., Heckman, G. A., Isaac, D., Jong, P., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70545-2 · Cited by 119
Pulmonary Syndrome in Patients With Thalassemia Major Receiving Intravenous Deferoxamine Infusions
Freedman, M. H., Grisaru, D., Olivieri, N., MacLusky, I., & Thorner, P. S. (1990) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1990.02150290059028 · Cited by 114
LONGITUDINAL STUDY OF CARDIAC FUNCTION IN THALASSEMIA MAJOR *
Ehlers, K. H., Levin, A. R., Markenson, A. L., Marcus, J. R., Klein, A. A., Hilgartner, M. W., & Engle, M. A. (1980) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1980.tb33678.x · Cited by 114
Nutritional deficiencies in iron overloaded patients with hemoglobinopathies
Claster, S., Wood, J. C., Noetzli, L. J., Carson, S., Hofstra, T. C., Khanna, R., & Coates, T. D. (2009) · American Journal of Hematology · doi:10.1002/ajh.21416 · Cited by 113
Self-citationLink, G., Konijn, A. M., Breuer, W. V., Cabantchik, Z. I., & Hershko, C. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.116487 · Cited by 110
Renal function in pediatric patients with β-thalassemia major
Aldudak, B., Bayazıt, A. K., Noyan, A., Özel, A., Anarat, A., Şaşmaz, İ., Kılınç, Y., Gali, E., Anarat, R., & Dikmen, N. (2000) · Pediatric Nephrology · doi:10.1007/s004670000434 · Cited by 110
Renal dysfunction in patients with thalassaemia
Quinn, C. T., Johnson, V. L., Kim, H., Trachtenberg, F. L., Vogiatzi, M. G., Kwiatkowski, J. L., Neufeld, E. J., Fung, E. B., Oliveri, N. F., Kirby-Allen, M. A., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08477.x · Cited by 109
T‐type calcium channel blockade improves survival and cardiovascular function in thalassemic mice
Kumfu, S., Chattipakorn, S. C., Chinda, K., Fucharoen, S., & Chattipakorn, N. (2012) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2012.01779.x · Cited by 106
Westwood, M. A., Anderson, L. J., Maceira, A. M., Shah, F., Prescott, E., Porter, J. B., Wonke, B., Walker, J. M., & Pennell, D. J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20915 · Cited by 106
Self-citationDecreased Sodium and Increased Transient Outward Potassium Currents in Iron-Loaded Cardiac Myocytes
Kuryshev, Y. A., Brittenham, G. M., Fujioka, H., Kannan, P., Shieh, C., Cohen, S. A., & Brown, A. M. (1999) · Circulation · doi:10.1161/01.cir.100.6.675 · Cited by 104
Combined chelation therapy with deferasirox and deferoxamine in thalassemia
Lal, A., Porter, J. B., Sweeters, N., Ng, V., Evans, P., Neumayr, L., Kurio, G. H., Harmatz, P., & Vichinsky, E. P. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.10.006 · Cited by 103
Self-citationTelfer, P. T., Warburton, F., Christou, S., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.009118 · Cited by 103
Adamkiewicz, T. V., Berkovitch, M., Krishnan, C., Polsinelli, C., Kermack, D., & Olivieri, N. F. (1998) · Clinical Infectious Diseases · doi:10.1086/515025 · Cited by 103
Onset of cardiac iron loading in pediatric patients with thalassemia major
Wood, J. C., Origa, R., Agus, A., Matta, G., Coates, T. D., & Galanello, R. (2008) · Haematologica · doi:10.3324/haematol.12513 · Cited by 103
Self-citationGuideline recommendations for heart complications in thalassemia major
Cogliandro, T., Derchi, G., Mancuso, L., Mayer, M. C., Pannone, B., Pepe, A., Pili, M., Bina, P., Cianciulli, P., Sanctis, V. D., et al. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f20847 · Cited by 100
Longitudinal Study of Survival and Causes of Death in Patients with Thalassemia Major in Greece
Ladis, V., Chouliaras, G., Berdousi, H., Kanavakis, E., & KATTAMIS, C. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.067 · Cited by 100
Kondo, N. I., Shimada, M., & Fukatsu, T. (1999) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.16.955 · Cited by 97
Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia
Porter, J. B., & Davis, B. A. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2002.0214 · Cited by 97
Self-citationMaggio, A., Vitrano, A., Capra, M., Cuccia, L., Gagliardotto, F., Filosa, A., Magnano, C., Rizzo, M., Caruso, V., Gerardi, C., et al. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.01.002 · Cited by 96
Marco, V. D., Capra, M., Angelucci, E., Borgna‐Pignatti, C., Telfer, P. T., Harmatz, P., Kattamis, A., Prossamariti, L., Filosa, A., Rund, D. G., et al. (2010) · Blood · doi:10.1182/blood-2009-11-248724 · Cited by 95
Farmaki, K., Tzoumari, I., & Pappa, C. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.03.007 · Cited by 94
Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload
Al‐Refaie, F. N., Sheppard, L. N., Nortey, P., Wonke, B., & Hoffbrand, A. V. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03318.x · Cited by 93
Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.
Lee, P., Mohammed, N., Marshall, L., Abeysinghe, R. D., Hider, R. C., Porter, J. B., & Singh, S. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07467-7 · Cited by 92
Self-citationRose, R. A., Sellan, M. E., Simpson, J. A., Izaddoustdar, F., Cifelli, C., Panama, B. K., Davis, M., Zhao, D., Markhani, M., Murphy, G. G., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.960401 · Cited by 91
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Ho, K. M., Sheridan, D., & Paterson, T. (2007) · Heart · doi:10.1136/hrt.2006.111492 · Cited by 89
Myocardial involvement in idiopathic hemochromatosis
Short, E. M., Winkle, R. A., & Billingham, M. E. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90838-x · Cited by 89
Kwiatkowski, J. L., Kim, H.-Y., Thompson, A. A., Quinn, C. T., Mueller, B. U., Odame, I., Giardina, P. J., Vichinsky, E. P., Boudreaux, J. M., Cohen, A. R., et al. (2012) · Blood · doi:10.1182/blood-2011-04-344507 · Cited by 88
Self-citationFabio, G., Minonzio, F., Delbini, P., Bianchi, A., & Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2006-04-016949 · Cited by 87
Atrial Fibrillation Ablation: State of the Art
Pappone, C., & Santinelli, V. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.063 · Cited by 87
Activated platelet‐derived microparticles in thalassaemia
Pattanapanyasat, K., Gonwong, S., Chaichompoo, P., Noulsri, E., Lerdwana, S., Sukapirom, K., Siritanaratkul, N., & Fucharoen, S. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06449.x · Cited by 86
Vichinsky, E. P., Bernaudin, F., Forni, G. L., Gardner, R. V., Hassell, K., Heeney, M. M., Inusa, B. P. D., Kutlar, A., Lane, P. A., Mathias, L., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08720.x · Cited by 85
Self-citationAessopos, A., Berdoukas, V. A., & Tsironi, M. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.01018.x · Cited by 80
Severe infections in thalassaemic patients: prevalence and predisposing factors
Rahav, G., Volach, V., Shapiro, M., Rund, D., Rachmilewitz, E. A., & Goldfarb, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06082.x · Cited by 79
Pennell, D. J., Porter, J. B., Cappellini, M. D., Chan, L. L., El-Beshlawy, A. M., Aydınok, Y., Ibrahim, H. M., Li, C. K., Viprakasit, V., Elalfy, M. S., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.031468 · Cited by 79
Self-citationWestwood, M. A., Wonke, B., Maceira, A. M., Prescott, E., Walker, J. M., Porter, J. B., & Pennell, D. J. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20379 · Cited by 79
Self-citationInternational survey of T2* cardiovascular magnetic resonance in -thalassemia major
Carpenter, J. P., Roughton, M., Pennell, D. J., & the Myocardial Iron in Thalassemia (MINT) Investigators (2013) · Haematologica · doi:10.3324/haematol.2013.083634 · Cited by 78
Self-citationAcute Changes in Renal Function Associated With Deferoxamine Therapy
Koren, G. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150210113029 · Cited by 78
Renal function in children with β-thalassemia major and thalassemia intermedia
Smolkin, V., Halevy, R., Levin, C., Mines, M., Sakran, W., Ilia, K., & Koren, A. (2008) · Pediatric Nephrology · doi:10.1007/s00467-008-0897-8 · Cited by 77
Light and shadows in the iron chelation treatment of haematological diseases
Maggio, A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06666.x · Cited by 77
Leung, T. Y., & Lao, T. T.-H. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.10.009 · Cited by 77
Aessopos, A., Fragodimitri, C., Karabatsos, F., Hatziliami, A., Yousef, J., Giakoumis, A., Dokou, A., Gotsis, E. D., Berdoukas, V. A., & Karagiorga, M. (2007) · Haematologica · doi:10.3324/haematol.10455 · Cited by 76
Ladis, V., Chouliaras, G. L., Berdoukas, V. A., Chatziliami, A., Fragodimitri, C., Karabatsos, F., Youssef, J., Kattamis, A., & Karagiorga‐Lagana, M. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01582.x · Cited by 76
Renal tubular function in β-thalassemia
Sumboonnanonda, A., Malasit, P., Tanphaichitr, V. S., Ong-Ajyooth, S., Sunthornchart, S., Pattanakitsakul, S., Petrarat, S., Assateerawatt, A., & Vongjirad, A. (1998) · Pediatric Nephrology · doi:10.1007/s004670050453 · Cited by 76
Combined iron chelation therapy
Galanello, R., Agus, A., Campus, S., Danjou, F., Giardina, P. J., & Grady, R. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05591.x · Cited by 75
Self-citationHider, R. C., & Zu, L. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457629 · Cited by 75
A Prospective Study of Hepatocellular Carcinoma Incidence in Thalassemia
Mancuso, A., Sciarrino, E., Renda, M. C., & Maggio, A. (2006) · Hemoglobin · doi:10.1080/03630260500455565 · Cited by 71
Maggio, A., Vitrano, A., Capra, M., Cuccia, L., Gagliardotto, F., Filosa, A., Romeo, M. A., Magnano, C., Caruso, V., Argento, C., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07609.x · Cited by 71
Evans, P., Kayyali, R., Hider, R. C., Eccleston, J., & Porter, J. B. (2010) · Translational research · doi:10.1016/j.trsl.2010.05.002 · Cited by 71
Self-citationVitamin D deficiency, cardiac iron and cardiac function in thalassaemia major
Wood, J. C., Claster, S., Carson, S., Menteer, J., Hofstra, T. C., Khanna, R., & Coates, T. D. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07135.x · Cited by 70
Self-citationKim, E., Giri, S. N., & Pessah, I. N. (1995) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1995.1008 · Cited by 70
Optimizing iron chelation strategies in β-thalassaemia major
Porter, J. B. (2009) · Blood Reviews · doi:10.1016/s0268-960x(09)70003-7 · Cited by 67
Self-citationChan, G., Chan, S., Ho, P., & Ha, S. (2009) · Hemoglobin · doi:10.3109/03630260903211888 · Cited by 67
Plein, S., Schulz‐Menger, J., Almeida, A. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq474 · Cited by 66
Wu, K., Chang, J., Tsai, C., & Peng, C. T. (2004) · Annals of Hematology · doi:10.1007/s00277-003-0820-0 · Cited by 64
Miskin, H., Yaniv, I., Berant, M., Hershko, C., & Tamary, H. (2003) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2003.00075.x · Cited by 64
Pennell, D. J., Carpenter, J., Roughton, M., & Cabantchik, Z. I. (2011) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-13-45 · Cited by 64
Self-citationCore Protein of Hepatitis C Virus Induces Cardiomyopathy
Omura, T., Yoshiyama, M., Hayashi, T., Nishiguchi, S., Kaito, M., Horiike, S., Fukuda, K., Inamoto, S., Kitaura, Y., Nakamura, Y., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000154263.70223.13 · Cited by 64
Endothelial Dysfunction and Oxidant Status in Pediatric Patients with Hemoglobin E-β Thalassemia
Kukongviriyapan, V., Somparn, N., Senggunprai, L., Prawan, A., Kukongviriyapan, U., & Jetsrisuparb, A. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9107-x · Cited by 62
Deferiprone Chelation Therapy for Thalassemia Major
Galanello, R., & Campus, S. (2009) · Acta Haematologica · doi:10.1159/000243800 · Cited by 61
Self-citationAmlodipine Reduces Cardiac Iron Overload in Patients with Thalassemia Major: A Pilot Trial
Fernandes, J. L., Sampaio, E. F., Fertrin, K. Y., Coelho, O. R., Loggetto, S. R., Piga, A. G., Veríssimo, M., & Saad, S. T. O. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.05.002 · Cited by 61
Self-citationPregnancy in patients with β-thalassemia intermedia: Outcome of mothers and newborns
Nassar, A. H., Usta, I. M., Rechdan, J. B., Koussa, S., Inati, A. C., & Taher, A. T. (2006) · American Journal of Hematology · doi:10.1002/ajh.20654 · Cited by 61
Association of Heart Failure in Homozygous β-Thalassemia With the Major Histocompatibility Complex
Kremastinos, D. T., Flevari, P., Spyropoulou, M., Vrettou, H., Tsiapras, D. P., & Stavropoulos‐Giokas, C. (1999) · Circulation · doi:10.1161/01.cir.100.20.2074 · Cited by 61
Daily labile plasma iron as an indicator of chelator activity in Thalassaemia major patients
Zanninelli, G., Breuer, W. V., & Cabantchik, Z. I. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07907.x · Cited by 59
Global vasomotor dysfunction and accelerated vascular aging in β-thalassemia major
Hahalis, G. N., Kremastinos, D. T., Terzis, G., Kalogeropoulos, A. P., Chrysanthopoulou, A., Καρακάντζα, Μ., Kourakli, A., Adamopoulos, S. N., Tselepis, A. D., Grapsas, N., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.030 · Cited by 59
Acquired Proximal Renal Tubular Dysfunction in β-Thalassemia Patients Treated With Deferasirox
Yacobovich, J., Stark, P., Barzilai‐Birenbaum, S., Krause, I., Pazgal, I., Yaniv, I., & Tamary, H. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181ec0c38 · Cited by 58
Pantalone, G. R., Renda, D., Valenza, F., D’Amato, F., Vitrano, A., Cassarà, F., Rigano, P., Salvo, V. D., Giangreco, A., Bevacqua, E., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08180.x · Cited by 58
Pathare, A. V., Taher, A. T., & Daar, S. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0838-z · Cited by 58
Update on Survival in Thalassemia Major
Telfer, P. T. (2009) · Hemoglobin · doi:10.3109/03630260903347336 · Cited by 57
Porter, J. B., Wood, J. C., Olivieri, N. F., Vichinsky, E. P., Taher, A. T., Neufeld, E. J., Giardina, P. J., Thompson, A. A., Moore, B., Evans, P., et al. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-38 · Cited by 57
Self-citationEarly detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy
Cianciulli, P., Sollecito, D., Sorrentino, F., Forte, L., Gilardi, E., Massa, A., Papa, G. F. S., & Carta, S. (1994) · Kidney International · doi:10.1038/ki.1994.295 · Cited by 56
Reversible Fanconi syndrome in a pediatric patient on deferasirox
Rheault, M. N., Bechtel, H., Neglia, J. P., & Kashtan, C. E. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22711 · Cited by 56
Lai, M. E., Grady, R. W., Vacquer, S., Pepe, A., Carta, M. P., Bina, P., Sau, F., Cianciulli, P., Maggio, A., Galanello, R., et al. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.05.005 · Cited by 51
Self-citationRenal aspects of thalassaemia a changing paradigm
Bhandari, S., & Galanello, R. (2012) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2012.01819.x · Cited by 51
Self-citationImpact of magnetic resonance imaging on cardiac mortality in thalassemia major
Chouliaras, G. L., Berdoukas, V. A., Ladis, V., Kattamis, A., Chatziliami, A., Fragodimitri, C., Karabatsos, F., Youssef, J., & Karagiorga‐Lagana, M. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22621 · Cited by 50
Kremastinos, D. T., Hamodraka, E. S., Parissis, J., Tsiapras, D. P., Dima, K., & Maisel, A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.025 · Cited by 50
Jensen, J. H., Tang, H., Tosti, C. L., Swaminathan, S. V., Nunez, A., Hultman, K. L., Szulc, K. U., Wu, E. X., Kim, D. C., Sheth, S., et al. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22273 · Cited by 50
Gharagozloo, M., Karimi, M., & Amirghofran, Z. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0564-y · Cited by 48
Cheung, Y., Chow, P., Chan, G., & Ha, S. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06349.x · Cited by 48
Kwiatkowski, J. (2011) · Journal of Blood Medicine · doi:10.2147/jbm.s13065 · Cited by 47
Blood Pressure and Heart Rate in Young Thalassemia Major Patients
Veglio, F. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00263-x · Cited by 45
Reversal of heart failure in thalassemia major by combined chelation therapy: a case report
Tsironi, M., Deftereos, S., Andriopoulos, P., Farmakis, D. T., Meletis, J., & Aessopos, A. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00335.x · Cited by 45
Deferasirox: pharmacokinetics and clinical experience
Galanello, R., Campus, S., & Origa, R. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.640674 · Cited by 44
Self-citationWood, J. C., Glynos, T., Thompson, A. A., Giardina, P. J., Harmatz, P., Kang, B. P. S., Paley, C. S., & Coates, T. D. (2011) · Haematologica · doi:10.3324/haematol.2010.032862 · Cited by 44
Self-citationMariotti, S., Loviselli, A., Murenu, S., Sau, F., Valentino, L., Mandas, A., Vacquer, S., Martino, E., Balestrieri, A., & Lai, M. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03345479 · Cited by 43
On myocardial siderosis and left ventricular dysfunction in hemochromatosis
Carpenter, J., Grasso, A. E., Porter, J. B., Shah, F., Dooley, J. S., & Pennell, D. J. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-24 · Cited by 43
Self-citationDifferential accumulation of non-transferrin-bound iron by cardiac myocytes and fibroblasts
Liu, Y. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00072-5 · Cited by 42
Mamtani, M., & Kulkarni, H. R. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07122.x · Cited by 42
Redox regulation of calcium release in skeletal and cardiac muscle
Hidalgo, C., Aracena-Parks, P., Sánchez, G., & Donoso, P. (2002) · Biological Research · doi:10.4067/s0716-97602002000200009 · Cited by 42
Cited by
Messroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0389-8 · Cited by 1,727
Normal values for cardiovascular magnetic resonance in adults and children
Kawel-Boehm, N., Maceira, A., Valsangiacomo-Buechel, E. R., Vogel-Claussen, J., Turkbey, E. B., Williams, R., Plein, S., Tee, M., Eng, J., & Bluemke, D. A. (2015) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-015-0111-7 · Cited by 746
Kawel-Boehm, N., Hetzel, S. J., Ambale-Venkatesh, B., Captur, G., Francois, C. J., Jerosch-Herold, M., Salerno, M., Teague, S. D., Valsangiacomo-Buechel, E., van der Geest, R. J., et al. (2020) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-020-00683-3 · Cited by 610
Overview of iron metabolism in health and disease
Dev, S., & Babitt, J. L. (2017) · Hemodialysis International · doi:10.1111/hdi.12542 · Cited by 462
Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000682 · Cited by 416
Metadata
- Authors
- Pennell, D. J., Udelson, J. E., Arai, A. E., Bozkurt, B., Cohen, A. R., Galanello, R., Hoffman, T. M., Kiernan, M. S., Lerakis, S., Piga, A., Porter, J. B., Walker, J. M., & Wood, J.
- Venue
- Circulation
- Published
- 2013-07-16
- Volume
- 128
- Issue
- 3
- Pages
- 281-308
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1983799237
- Cited by
- 394
- References
- 239
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.